Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Tempus AI is projected to achieve 30% YoY top line growth in Q4 2024 as presented in its preliminary results. Click here to ...

Mr Rajarshi (Rishi) Mukherjee, a Ronald Finn Senior Research Fellow has become the first recipient of the prestigious Medical ...

Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.

A Hull company that manufactures laboratory furniture for schools, universities, and government projects has announced a change in its leadership.

A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...

The Marketing Association of Pakistan (MAP) has announced its newly elected office bearers and council members, as per a press release. Muhammad Azfar Ahsan, Founder & Chairman, Nutshell Group, has ...